studi
carri
calv
admit
clinic
cattl
calv
chosen
base
follow
select
criteria
age
day
neonat
diarrhea
defin
soupi
wateri
consist
fece
dehydr
distanc
medial
canthu
eyebal
least
mm
suckl
reflex
clinic
symptom
indic
moder
sever
secondari
organ
diseas
immedi
admiss
calf
weigh
gener
condit
assess
use
score
system
agil
physiolog
slight
depress
abl
stand
moder
depress
sternal
recumb
sever
depress
later
recumb
nippl
bottl
fill
milk
offer
anim
assess
suckl
reflex
extent
enophthalmu
quantifi
estim
distanc
medial
canthu
eyebal
mm
respiratori
rate
heart
rate
rectal
temperatur
assess
lung
auscult
navel
well
joint
examin
carri
exclud
secondari
diseas
check
clinic
investig
select
criteria
fulfil
blood
collect
jugular
vein
assess
pcv
serum
variabl
blood
gase
centrifug
blood
minut
took
place
within
minut
withdraw
final
grab
sampl
fece
taken
ampulla
recti
test
rotaviru
coronaviru
cryptosporidium
parvum
e
coli
f
salmonella
fecal
cultur
b
initi
treatment
conduct
introduc
venou
cathet
c
jugular
vein
studi
calf
receiv
mlkg
bodi
weight
bw
salin
solut
minut
studi
nacl
correspond
mmol
naclkg
bw
studi
ii
calf
receiv
mlkg
bw
bicarbon
solut
e
minut
studi
ii
correspond
mmol
bw
immedi
inject
calv
allow
suckl
l
or
calv
refus
drink
administ
fluid
drencher
f
minut
inject
or
contain
per
liter
g
nacl
g
kcl
g
g
glucos
calcul
osmolar
mosmol
g
iukg
bw
sc
administ
day
addit
blood
sampl
withdrawn
randomli
chosen
calv
studi
minut
inject
assess
serum
concentr
sodium
potassium
chlorid
studi
ii
determin
statu
studi
ii
clinic
examin
carri
hour
initi
treatment
clinic
examin
blood
collect
jugular
vein
assess
pcv
serum
variabl
statu
fecal
grab
sampl
approxim
ml
taken
clinic
investig
kept
frozen
subsequ
dri
matter
dm
determin
milk
replac
h
mr
gl
correspond
bw
per
day
offer
divid
meal
pm
pm
or
avail
nippl
bucket
pm
pm
pm
respect
recumb
calv
encourag
drink
or
least
minut
time
intak
mr
or
record
treatment
failur
defin
deterior
gener
condit
consecut
clinic
investig
monitor
period
exclus
studi
calv
treat
establish
protocol
ie
continu
infus
isoton
solut
ear
vein
l
salin
solut
l
glucos
solut
l
bicarbon
solut
pcv
measur
hemogram
analyz
venou
blood
ph
base
excess
partial
pressur
carbon
dioxid
standard
bicarbon
determin
blood
ga
analyz
j
serum
concentr
total
protein
tp
urea
sodium
chlorid
potassium
determin
automat
analyz
system
k
concentr
plasma
measur
quantit
enzymat
test
l
thaw
fecal
sampl
dm
content
assess
weigh
sampl
twice
dri
process
hour
anion
gap
ag
calcul
strong
ion
gap
sig
calcul
accord
constabl
et
al
sigmastat
use
statist
analysi
result
result
differ
significantli
normal
distribut
indic
test
present
mean
standard
deviat
otherwis
depict
median
quartil
signific
differ
treatment
studi
ii
test
test
respect
differ
point
time
within
studi
group
check
analysi
varianc
anova
anova
rank
respect
signific
differ
proport
treatment
failur
studi
ii
test
fisher
exact
test
differ
classifi
signific
p
infecti
agent
found
fecal
smear
calv
investig
e
coli
f
detect
calv
mix
infect
either
rotaviru
c
parvum
coronaviru
c
parvum
evid
calv
calv
respect
exclus
c
parvum
found
calv
salmonella
found
fece
none
calv
patient
infect
e
coli
f
younger
metabol
acidosi
sever
compar
calv
suffer
neonat
diarrhea
caus
viral
cryptosporidium
infect
fig
statu
calv
hyperton
rehydr
indic
profound
diarrhea
moder
sever
dehydr
moder
sever
depress
pronounc
metabol
acidosi
hyperton
rehydr
use
salin
studi
success
calv
six
calv
remov
hour
inject
treatment
failur
averag
day
older
exhibit
treatment
sever
acidemia
ph
mm
mm
compar
success
treat
calv
ph
mm
mm
differ
success
treat
calv
treatment
failur
found
tabl
hyperton
rehydr
use
bicarbon
solut
studi
ii
success
calv
sole
calf
success
resuscit
hyperton
sodium
bicarbon
remov
hour
applic
hyperton
solut
calf
sever
metabol
acidosi
ph
mm
treatment
despit
slight
dehydr
bw
pcv
urea
mm
proport
treatment
failur
hour
inject
significantli
higher
studi
nacl
compar
studi
ii
p
inject
clinic
import
advers
effect
occur
administr
hyperton
solut
roughli
calv
exhibit
sign
discomfort
moder
sever
restless
inject
hyperton
solut
indic
twitch
limb
gener
shiver
occasion
groan
obviou
differ
respect
extent
clinic
sign
observ
calv
studi
nacl
studi
ii
howev
applic
hb
respiratori
rate
increas
profoundli
roughli
breath
per
minut
compar
calv
treat
hyperton
salin
sign
disappear
gradual
within
minut
inject
calv
nine
calv
studi
nacl
calv
studi
ii
drank
voluntarili
l
or
within
minut
inject
hyperton
solut
remain
calv
receiv
or
drench
forthcom
comparison
variou
variabl
obtain
calv
studi
nacl
studi
ii
carri
exclus
calv
still
remain
studi
thu
higher
percentag
treatment
failur
studi
nacl
compar
studi
ii
taken
account
gener
condit
calv
studi
improv
significantli
within
hour
inject
mean
clinic
score
moder
depress
sternal
recumb
mean
clinic
score
slight
depress
abl
stand
tabl
success
treat
calv
studi
clinic
statu
calv
improv
furthermor
result
almost
undisturb
gener
behavior
major
calv
hour
inject
signific
chang
rectal
temperatur
heart
rate
respiratori
rate
found
investig
period
hour
calv
studi
tabl
studi
concomit
improv
gener
condit
dehydr
patient
could
correct
within
hour
inject
enophthalmu
significantli
reduc
alreadi
within
hour
slower
improv
obviou
within
subsequ
hour
tabl
pcv
decreas
calv
studi
within
hour
roughli
constant
valu
reach
studi
hour
inject
tabl
serum
concentr
tp
decreas
almost
linearli
studi
within
hour
inject
initi
gl
roughli
gl
remain
investig
period
studi
urea
concentr
decreas
mm
studi
ii
administr
hyperton
solut
significantli
hour
inject
mm
tabl
metabol
acidosi
calv
studi
equal
gradual
within
roughli
hour
indic
increas
blood
ph
salin
applic
hour
inject
correct
within
hour
mm
salin
applic
versu
mm
hour
inject
tabl
faster
pronounc
increas
plasma
ph
observ
calv
studi
ii
effect
hyperton
bicarbon
applic
assess
detail
evalu
effect
subgroup
patient
tabl
result
reveal
calv
becam
serious
alkalem
inject
period
ph
mm
measur
directli
inject
period
howev
transient
effect
alreadi
minut
later
plasma
ph
reach
upper
limit
refer
rang
ph
decreas
furthermor
minut
inject
six
hour
inject
plasma
ph
averag
mean
mm
tabl
although
plasma
ph
tend
decreas
subsequ
hour
seriou
acidemia
develop
indic
ph
end
investig
period
hour
inject
basal
serum
concentr
decreas
linearli
studi
within
hour
inject
mm
approxim
mm
remain
level
investig
period
tabl
calv
studi
nacl
serum
sodium
concentr
increas
significantli
mean
basal
valu
mm
salin
applic
mm
measur
hour
inject
calv
studi
ii
massiv
transient
hypernatremia
evid
result
collect
sampl
calv
tabl
howev
hour
applic
hb
mean
sodium
concentr
physiolog
rang
mm
subsequ
hour
mean
concentr
mm
found
tabl
serum
chlorid
concentr
increas
calv
receiv
hyperton
salin
studi
within
minut
inject
significantli
mm
thereaft
valu
within
refer
rang
found
studi
ii
signific
chang
serum
chlorid
concentr
observ
hyperton
rehydr
hyperton
rehydr
hyperkalemia
found
calv
studi
mm
distinct
bradyarrhythmia
hyperkalemia
howev
detect
tabl
gradual
decreas
level
mm
observ
within
hour
studi
subsequ
hour
serum
concentr
remain
rang
without
signific
differ
calv
studi
tabl
intak
mr
differ
calv
studi
tend
increas
p
day
day
hyperton
rehydr
day
l
day
l
day
l
mean
sd
also
intak
or
differ
calv
studi
tend
decreas
p
day
day
initi
treatment
day
l
day
l
day
l
thu
amount
total
fluid
intak
remain
constant
averag
ld
studi
nacl
mean
percentag
fecal
dm
remain
within
investig
period
without
signific
differ
studi
ii
signific
differ
calv
studi
nacl
evid
day
initi
treatment
fecal
dm
rang
mean
valu
tabl
object
evalu
clinic
efficaci
differ
hyperton
iv
rehydr
solut
inappet
diarrheic
calv
prevent
adulter
posit
effect
hyperton
rehydr
insuffici
organ
patient
addit
secondari
infect
disregard
health
problem
explain
partli
long
histori
neonat
diarrhea
also
high
proport
hypogammaglobulinemia
insuffici
colostr
suppli
among
diarrheic
calv
confirm
low
serum
concentr
tp
success
rehydr
studi
tabl
catabol
state
intestin
protein
loss
diarrhea
may
impact
mani
author
recommend
hyperton
salin
dextran
rehydr
present
studi
differ
concentr
salin
use
solut
licens
commerci
avail
germani
repres
prerequisit
applic
food
anim
nevertheless
mlkg
bw
solut
administ
wherea
mlkg
recommend
higher
concentr
salin
almost
amount
sodium
versu
mmolkg
bw
given
patient
ensur
compar
result
hyperton
solut
use
present
studi
contain
dextran
licens
germani
food
anim
addit
dextran
induc
pronounc
expans
plasma
volum
sustain
effect
compar
hyperton
salin
without
dextran
predominantli
intravascular
distribut
dextran
capac
roughli
ml
water
per
gram
dextran
thu
shorter
effect
hyperton
salin
studi
plasma
volum
compar
studi
carri
sodium
chlorid
dextran
solut
expect
continu
iv
infus
isoton
solut
effect
gentl
approach
treatment
sever
diarrheic
calv
hyperton
rehydr
repres
altern
rehydr
patient
infus
treatment
carri
reason
primari
therapeut
approach
base
transient
replenish
intravascular
volum
intracellular
transcellular
compart
caus
increas
plasma
osmolar
therebi
cardiovascular
system
stabil
minut
sustain
improv
clinic
statu
howev
requir
signific
oral
intak
fluid
contain
water
electrolyt
buffer
energi
present
studi
principl
work
success
calv
studi
nacl
calv
studi
ii
rehydr
accompani
mark
improv
gener
condit
restor
suckl
reflex
achiev
within
hour
period
compar
success
treatment
base
continu
infus
isoton
solut
differ
proport
treatment
failur
studi
nacl
studi
ii
explain
predominantli
advantag
bicarbon
solut
treatment
diarrheic
calv
sever
metabol
acidosi
differ
exist
statu
calv
hyperton
rehydr
success
treat
calv
treatment
failur
except
sever
acidemia
latter
calv
fail
respond
averag
older
success
treat
calv
indirectli
confirm
find
diarrheic
calv
older
week
age
exhibit
sever
acidemia
younger
calv
tabl
explan
infect
rotaviru
coronaviru
c
parvum
induc
osmot
diarrhea
accompani
microbi
ferment
substrat
larg
intestin
lead
excess
product
predominantli
calv
treat
hb
studi
ii
receiv
doubl
load
sodium
compar
calv
studi
nacl
sodium
regard
major
determin
rehydr
success
howev
obviou
differ
found
respect
veloc
rehydr
calv
studi
ii
tabl
thu
concentr
sodium
hyperton
solut
short
transient
effect
wherea
final
success
rehydr
treatment
determin
predominantli
suffici
intak
or
unfortun
sever
metabol
acidosi
recumb
diarrheic
calv
mm
may
slightli
aggrav
applic
administ
continu
infus
hyperton
inject
salin
creat
strong
ion
acidosi
effect
sid
calf
plasma
meql
wherea
effect
sid
salin
meql
administr
ml
salin
kg
bw
within
minut
decreas
plasma
ph
swine
hemorrhag
shock
mix
acidosi
ph
unit
decreas
consid
clinic
inconsequenti
predominantli
improv
blood
ph
achiev
intak
buffer
or
calv
sever
acidemia
howev
decreas
plasma
ph
hyperton
salin
applic
may
detriment
respect
restor
suckl
reflex
crucial
import
intak
or
repres
prerequisit
success
rehydr
treatment
neg
correl
suggest
degre
acidosi
vigor
suckl
reflex
also
studi
sustain
improv
oral
fluid
intak
achiev
predominantli
calv
acidemia
could
correct
quickli
calv
hyperton
rehydr
fail
gener
condit
deterior
concomit
reduct
oral
fluid
intak
face
prolong
acidemia
concentr
like
massiv
increas
diarrheic
calv
studi
compar
healthi
calv
indic
profoundli
increas
ag
tabl
increas
concentr
contribut
significantli
weak
disturb
conscious
seem
influenc
suckl
reflex
administr
hb
repres
therapeut
option
correct
metabol
acidosi
faster
hyperton
salin
even
calv
mm
treat
success
plasma
ph
increas
alreadi
within
hour
physiolog
valu
calv
mlkg
bw
bicarbon
solut
provid
buffer
capac
suffici
equal
mm
high
effect
sid
meql
strong
ion
alkalosi
induc
measur
calv
tabl
doubl
amount
sodium
compar
ml
salin
kg
bw
administ
lead
question
whether
applic
ml
bicarbon
solut
kg
bw
within
minut
hazard
patient
hyperton
salin
three
issu
taken
account
buffer
capac
bicarbon
requir
effect
remov
respiratori
system
tachypnea
pronounc
calv
receiv
hyperton
bicarbon
salin
like
hypercapnia
tabl
studi
ii
sever
calv
slight
metabol
acidosi
treat
requir
buffer
capac
nevertheless
also
patient
problem
cope
applic
hyperton
bicarbon
enhanc
ventil
even
newborn
calv
mix
respiratori
acidosi
dystocia
mean
blood
ph
success
treat
infus
averag
ml
sodium
bicarbon
solut
minut
combin
doxapram
iv
intranas
oxygen
insuffl
neg
effect
compar
calv
treat
carbicarb
found
also
rapid
iv
administr
hb
mlkg
minut
found
effect
safe
treat
strong
ion
acidosi
normovolem
calv
experiment
induc
respiratori
strong
ion
acidosi
studi
howev
lower
amount
bicarbon
infus
studi
ii
present
mani
calv
especi
longer
histori
diarrhea
also
suffer
respiratori
infect
remain
unknown
whether
remov
excess
applic
hb
hyperventil
possibl
patient
report
practition
sudden
fatal
calv
hyperton
bicarbon
infus
may
indic
incid
could
relat
respiratori
insuffici
present
recommend
avoid
applic
hyperton
bicarbon
calv
suffer
sever
respiratori
diseas
wherea
hyperton
salin
also
appli
patient
impair
abil
remov
carbon
dioxid
pia
rapid
inject
larg
quantiti
bicarbon
discuss
matter
concern
accordingli
bicarbon
ion
react
h
ion
form
readili
enter
cell
overwhelm
barrier
high
solubl
thu
intracellular
increas
induc
local
respiratori
acidosi
clinic
consequ
unclear
postul
acidif
cerebrospin
fluid
csf
may
exagger
depress
increas
respiratori
rate
pia
demonstr
vitro
studi
increas
extracellular
approxim
mmhg
howev
vivo
rare
increas
mmhg
suggest
increas
bicarbon
applic
aggrav
concomit
releas
proton
extracellular
nonbicarbon
buffer
sever
acidot
patient
berchtold
et
al
induc
experiment
mix
respiratori
metabol
acidosi
calv
found
subsequ
inject
bicarbon
solut
mlkg
bw
minut
ph
chang
csf
irrespect
transient
increas
arteri
mmhg
turnov
rate
csf
calcul
patient
statist
trend
p
found
relat
plasma
ph
inject
hyperton
bicarbon
increas
venou
inject
tabl
howev
increas
averag
mmhg
directli
initi
treatment
thu
pia
seem
reason
profound
problem
hyperton
bicarbon
applic
calv
healthi
respiratori
express
respect
iv
treatment
diarrheic
calv
bicarbon
solut
concomit
hypercapnia
remov
metabol
acidosi
may
worsen
oxygen
extract
peripher
tissu
patient
base
result
present
concern
seem
inappropri
despit
extens
transient
metabol
alkalosi
immedi
inject
hb
tabl
explain
incomplet
distribut
bicarbon
extracellular
space
gener
condit
calv
receiv
bicarbon
solut
improv
improv
blood
flow
increas
plasma
volum
overwhelm
neg
impact
left
shift
oxygen
equilibrium
curv
oral
fluid
intak
crucial
import
success
hyperton
rehydr
intens
fosterag
calf
initi
treatment
repres
prerequisit
recoveri
critic
ill
patient
undoubtedli
facilit
provid
mani
small
meal
variat
milk
well
or
intak
meal
hyperton
rehydr
high
thu
calv
studi
ii
fed
time
per
day
moreov
high
feed
frequenc
reduc
risk
long
period
low
ph
abomasum
favor
develop
abomas
ulcer
hypernatremia
serum
sodium
mm
dread
syndrom
diarrheic
calv
often
oral
applic
or
inadequ
composit
sodium
mm
result
present
studi
indic
hypernatremia
problem
calv
hyperton
salin
mlkg
hyperton
bicarbon
mlkg
correspond
kg
calf
total
mmol
sodium
respect
serum
sodium
increas
immedi
complet
inject
hb
mm
trigger
increas
plasma
osmolar
roughli
mosmol
increas
rang
also
report
immedi
dilut
extracellular
compart
influx
intracellular
transcellular
fluid
exclud
risk
clinic
signific
hypernatremia
howev
hyperton
rehydr
inappropri
calv
alreadi
suffer
hypernatremia
initi
treatment
conclus
hyperton
rehydr
repres
safe
reliabl
method
improv
hydrat
statu
inappet
diarrheic
calv
hyperton
salin
seem
appropri
calv
within
week
life
patient
suffer
slight
moder
metabol
acidosi
mm
hb
allow
success
treatment
diarrheic
calv
even
sever
metabol
acidosi
mm
frequent
found
diarrheic
calv
older
week
diarrheic
patient
also
suffer
respiratori
diseas
treat
hb
high
oral
fluid
intak
precondit
success
hyperton
treatment
requir
adequ
fosterag
adigest
kit
rota
corona
e
coli
f
cryptosporidium
diagnost
sprl
innov
veterinari
diagnost
jemel
belgium
hannov
hannov
germani
mm
vygon
gmbh
co
kg
aachen
germani
ml
sodium
chlorid
ingredi
mmolml
aqua
dest
excipi
serumwerk
bernburg
ag
bernburg
germani
enatriumhydrogencarbonat
b
braun
ml
sodium
bicarbon
ingredi
mmolml
aqua
dest
excipi
b
braun
melsungen
ag
melsungen
germani
fcalf
drencher
flexibl
l
jorgen
kruus
marslev
denmark
gprocillin
benzylpenicillin
ingredi
iuml
excipi
alvetra
gmbh
germani
hnormi
typ
f
nordmilch
zeven
industriestrass
zeven
germani
ihematolog
analyz
model
nihon
kohden
europ
gmbh
rosbach
v
h
germani
jrapidlab
bayer
vital
gmbh
fernwald
germani
kcoba
mira
roch
ltd
basel
switzerland
lsigma
diagnost
laktat
nr
chemi
gmbh
taufkirchen
germani
mjandel
scientif
corp
lo
angel
ca
